1. Home
  2. IMXI vs FULC Comparison

IMXI vs FULC Comparison

Compare IMXI & FULC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMXI
  • FULC
  • Stock Information
  • Founded
  • IMXI 1994
  • FULC 2015
  • Country
  • IMXI United States
  • FULC United States
  • Employees
  • IMXI N/A
  • FULC N/A
  • Industry
  • IMXI Retail: Computer Software & Peripheral Equipment
  • FULC Biotechnology: Pharmaceutical Preparations
  • Sector
  • IMXI Technology
  • FULC Health Care
  • Exchange
  • IMXI Nasdaq
  • FULC Nasdaq
  • Market Cap
  • IMXI 414.7M
  • FULC 469.0M
  • IPO Year
  • IMXI N/A
  • FULC 2019
  • Fundamental
  • Price
  • IMXI $13.95
  • FULC $9.51
  • Analyst Decision
  • IMXI Buy
  • FULC Buy
  • Analyst Count
  • IMXI 5
  • FULC 6
  • Target Price
  • IMXI $19.60
  • FULC $8.67
  • AVG Volume (30 Days)
  • IMXI 320.2K
  • FULC 537.7K
  • Earning Date
  • IMXI 11-07-2025
  • FULC 11-12-2025
  • Dividend Yield
  • IMXI N/A
  • FULC N/A
  • EPS Growth
  • IMXI N/A
  • FULC N/A
  • EPS
  • IMXI 1.65
  • FULC N/A
  • Revenue
  • IMXI $642,149,000.00
  • FULC N/A
  • Revenue This Year
  • IMXI N/A
  • FULC N/A
  • Revenue Next Year
  • IMXI $1.87
  • FULC N/A
  • P/E Ratio
  • IMXI $8.51
  • FULC N/A
  • Revenue Growth
  • IMXI N/A
  • FULC 2752.05
  • 52 Week Low
  • IMXI $8.58
  • FULC $2.32
  • 52 Week High
  • IMXI $22.37
  • FULC $9.70
  • Technical
  • Relative Strength Index (RSI)
  • IMXI 46.50
  • FULC 73.21
  • Support Level
  • IMXI $13.91
  • FULC $8.33
  • Resistance Level
  • IMXI $14.28
  • FULC $9.70
  • Average True Range (ATR)
  • IMXI 0.12
  • FULC 0.51
  • MACD
  • IMXI -0.13
  • FULC 0.17
  • Stochastic Oscillator
  • IMXI 5.69
  • FULC 92.00

About IMXI International Money Express Inc.

International Money Express Inc is a processor of money transfer services in the USA to the Latin America and the Caribbean (LAC) corridor. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About FULC Fulcrum Therapeutics Inc.

Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.

Share on Social Networks: